Jo-Ann Latkowski, MD, FAAD
SESSIONS
U021 Immunomodulatory Therapies and Cutaneous Lymphoma: Associations, Risks, and Clinical Implications
Mar 27, 2026
•
3:30 PM - 4:30 PM
•
Mile High 3A
DISCLOSURES
No financial relationships exist with ineligible companies.